Myovant Sciences Analysis
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
Myovant Sciences is overvalued with Real Value of 22.9 and Hype Value of 26.98. The main objective of Myovant Sciences delisted stock analysis is to determine its intrinsic value, which is an estimate of what Myovant Sciences is worth, separate from its market price. There are two main types of Myovant Sciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Myovant Sciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Myovant Sciences' stock to identify patterns and trends that may indicate its future price movements.
The Myovant Sciences stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Myovant Sciences is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Myovant Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Myovant Sciences' ongoing operational relationships across important fundamental and technical indicators.
Myovant |
Myovant Stock Analysis Notes
About 49.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.92. Myovant Sciences had not issued any dividends in recent years. Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 579 people. To find out more about Myovant Sciences contact the company at 44 20 7400 3351 or learn more at https://myovant.com.Myovant Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Myovant Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Myovant Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Myovant Sciences is not yet fully synchronised with the market data | |
| Myovant Sciences has a very high chance of going through financial distress in the upcoming years | |
| Myovant Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the previous year's revenue of 230.97 M. Net Loss for the year was (205.98 M) with profit before overhead, payroll, taxes, and interest of 72.02 M. | |
| Myovant Sciences currently holds about 371.29 M in cash with (268.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.84. | |
| Roughly 56.0% of the company shares are owned by institutional investors |
Myovant Sciences Upcoming and Recent Events
Earnings reports are used by Myovant Sciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Myovant Sciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 9th of May 2023 Upcoming Quarterly Report | View | |
| 26th of July 2023 Next Financial Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View | |
| 9th of May 2023 Next Fiscal Year End | View | |
| 31st of December 2022 Last Quarter Report | View | |
| 31st of March 2022 Last Financial Announcement | View |
Myovant Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Myovant Sciences's market, we take the total number of its shares issued and multiply it by Myovant Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Myovant Profitablity
Myovant Sciences' profitability indicators refer to fundamental financial ratios that showcase Myovant Sciences' ability to generate income relative to its revenue or operating costs. If, let's say, Myovant Sciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Myovant Sciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Myovant Sciences' profitability requires more research than a typical breakdown of Myovant Sciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.48) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.39) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.39. Myovant Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Myovant Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Myovant Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Myovant Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sumitomo Chemical Co Ltd over a year ago Acquisition or disposition of Myovant Sciences securities by Sumitomo Chemical Co Ltd |
Myovant Sciences Predictive Daily Indicators
Myovant Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Myovant Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Myovant Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Myovant Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Myovant shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Myovant Sciences. By using and applying Myovant Stock analysis, traders can create a robust methodology for identifying Myovant entry and exit points for their positions.
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 579 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Myovant Sciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |